All Stories

  1. Pharmacogenetics of alcohol use disorder treatments: an update

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2019, Taylor & Francis

    Dr Henry R Kranzler

  2. Maintenance of drinking reductions are possible and associated with improvements in functioning.

    Article • Alcoholism Clinical and Experimental Research, April 2019, Wiley

    Dr. Katie Witkiewitz, Dr Henry R Kranzler

  3. F123. Genome-Wide Epigenetic Signatures of Major Depressive Disorder in Women

    Article • Biological Psychiatry, May 2018, Elsevier

    Dr Henry R Kranzler

  4. Predictors of Treatment Referral After AUDIT-C Screening for Heavy Drinking

    Article • Addictive Disorders & Their Treatment, April 2018, Wolters Kluwer Health

    Dr Henry R Kranzler

  5. Examining the effects of alcohol on GABA A receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells

    Article • Alcohol, February 2018, Elsevier

    Dr Henry R Kranzler

  6. Collaborative phenotype inference from comorbid substance use disorders and genotypes

    Article • November 2017, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Henry R Kranzler

  7. Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals

    Article • Addictive Disorders & Their Treatment, September 2017, Wolters Kluwer Health

    Dr Henry R Kranzler

  8. S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis of risky sexual behaviours

    Article • Journal of Psychiatry and Neuroscience, July 2017, Canadian Medical Association (CMA)

    Dr Henry R Kranzler

  9. Correlates of Electronic Cigarettes Use Before and During Pregnancy

    Article • Nicotine & Tobacco Research, April 2017, Oxford University Press (OUP)

    Dr Henry R Kranzler

  10. Genomewide Association Study of Alcohol Dependence Identifies Risk Loci Altering Ethanol-Response Behaviors in Model Organisms

    Article • Alcoholism Clinical and Experimental Research, March 2017, Wiley

    Dr Henry R Kranzler, Danielle Dick

  11. Alcohol and nicotine codependence-associated DNA methylation changes in promoter regions of addiction-related genes

    Article • Scientific Reports, February 2017, Springer Science + Business Media

    Dr Henry R Kranzler

  12. Effects of LY466195, a selective kainate receptor antagonist, on ethanol preference and drinking in rats

    Article • Neuroscience Letters, February 2017, Elsevier

    Dr Henry R Kranzler

  13. Examining FKBP5 mRNA expression in human iPSC-derived neural cells

    Article • Psychiatry Research, January 2017, Elsevier

    Dr Henry R Kranzler

  14. Genetic Factor Common To Schizophrenia And Hiv Infection Is Associated With Risky Sexual Behavior

    Article • European Neuropsychopharmacology, January 2017, Elsevier

    Dr Henry R Kranzler

  15. Urgency traits moderate daily relations between affect and drinking to intoxication among young adults

    Article • Drug and Alcohol Dependence, January 2017, Elsevier

    Dr Henry R Kranzler

  16. Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision

    Article • The World Journal of Biological Psychiatry, December 2016, Taylor & Francis

    Dr Henry R Kranzler

  17. Phenome-Wide Association Study for Alcohol and Nicotine Risk Alleles in 26394 Women

    Article • Neuropsychopharmacology, May 2016, Nature

    Dr Henry R Kranzler

  18. Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks

    Article • JAMA Psychiatry, May 2016, American Medical Association (AMA)

    Dr Henry R Kranzler

  19. New Initiatives forAlcoholism: Clinical and Experimental Research

    Article • Alcoholism Clinical and Experimental Research, February 2016, Wiley

    Dr Henry R Kranzler

  20. Balancing Risk and Benefit in Heavy Drinkers Treated With Topiramate

    Article • The Journal of Clinical Psychiatry, February 2016, Physicians Postgraduate Press, Inc

    Dr Henry R Kranzler

  21. An Effective Method to Identify Heritable Components from Multivariate Phenotypes

    Article • PLoS ONE, December 2015, PLOS

    Dr Henry R Kranzler

  22. Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care

    Article • Addictive Disorders & Their Treatment, December 2015, Wolters Kluwer Health

    Dr Henry R Kranzler

  23. Genome-wide association study of body mass index in subjects with alcohol dependence

    Article • Addiction Biology, October 2015, Wiley

    Dr Henry R Kranzler

  24. Refining multivariate disease phenotypes for high chip heritability

    Article • BMC Medical Genomics, September 2015, Springer Science + Business Media

    Dr Henry R Kranzler

  25. Further analyses support the association between light eye color and alcohol dependence

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, August 2015, Wiley

    Dr Henry R Kranzler

  26. GABRA2Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAASubunit Genes in Human Neural Cultures

    Article • Alcoholism Clinical and Experimental Research, August 2015, Wiley

    Dr Henry R Kranzler

  27. Psychopharmacological Treatments for Substance Use Disorders

    Article • August 2015, Oxford University Press (OUP)

    Dr Henry R Kranzler

  28. Endorsement of the CONSORT Principles in Reporting Alcohol Clinical Trials inACER

    Article • Alcoholism Clinical and Experimental Research, July 2015, Wiley

    Dr Henry R Kranzler

  29. Eye color: A potential indicator of alcohol dependence risk in European Americans

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2015, Wiley

    Dr Henry R Kranzler

  30. Genetic Vulnerability to Menthol Cigarette Preference in Women

    Article • Nicotine & Tobacco Research, April 2015, Oxford University Press (OUP)

    Dr Henry R Kranzler

  31. Which alcohol use disorder criteria contribute to the association ofADH1Bwith alcohol dependence?

    Article • Addiction Biology, April 2015, Wiley

    Dr Henry R Kranzler

  32. Genetics of Addiction

    Article • December 2014, American Psychiatric Association

    Dr Henry R Kranzler

  33. Posttreatment Effects of Topiramate Treatment for Heavy Drinking

    Article • Alcoholism Clinical and Experimental Research, December 2014, Wiley

    Dr Henry R Kranzler

  34. Identifying heritable composite traits from multivariate phenotypes and genome-wide SNPs

    Article • November 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Henry R Kranzler

  35. Genome-Wide Association Study of Copy Number Variations (CNVs) with Opioid Dependence

    Article • Neuropsychopharmacology, September 2014, Nature

    Tetyana Zayats, Dr Henry R Kranzler

  36. What happens when people discontinue taking medications? Lessons from COMBINE

    Article • Addiction, September 2014, Wiley

    Dr Robert Loren Stout, Dr Henry R Kranzler

  37. ACER: Quo Vadis?

    Article • Alcoholism Clinical and Experimental Research, July 2014, Wiley

    Dr Henry R Kranzler

  38. Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol

    Article • Psychopharmacology, May 2014, Springer Science + Business Media

    Dr Henry R Kranzler

  39. GRIK1 Genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink

    Article • The International Journal of Neuropsychopharmacology, April 2014, Oxford University Press (OUP)

    Dr Henry R Kranzler

  40. Pharmacotherapy of Alcohol Use Disorders: Seventy-Five Years of Progress

    Article • Journal of Studies on Alcohol and Drugs Supplement, March 2014, Alcohol Research Documentation, Inc.

    Dr Henry R Kranzler

  41. Pharmacotherapy of Alcohol Use Disorders: Seventy-Five Years of Progress

    Article • Journal of Studies on Alcohol and Drugs Supplement, March 2014, Alcohol Research Documentation, Inc.

    Dr Henry R Kranzler

  42. Multiview Comodeling to Improve Subtyping and Genetic Association of Complex Diseases

    Article • IEEE Journal of Biomedical and Health Informatics, March 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Henry R Kranzler

  43. Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment

    Article • Psychopharmacology, February 2014, Springer Science + Business Media

    Dr Henry R Kranzler

  44. Rate of progression from first use to dependence on cocaine or opioids: A cross-substance examination of associated demographic, psychiatric, and childhood risk factors

    Article • Addictive Behaviors, February 2014, Elsevier

    Dr Henry R Kranzler

  45. The effects of aMAP2K5microRNA target site SNP on risk for anxiety and depressive disorders

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2014, Wiley

    Dr Henry R Kranzler

  46. Multi-view singular value decomposition for disease subtyping and genetic associations

    Article • BMC Genetics, January 2014, Springer Science + Business Media

    Dr Henry R Kranzler

  47. Bilingual Semi-Structured Assessment for Drug Dependence and Alcoholism--English/Samoan Version

    Article • January 2014, American Psychological Association (APA)

    Dr Henry R Kranzler

  48. Ttn as a likely causal gene for QTL of alcohol preference on mouse chromosome 2

    Article • BMC Bioinformatics, January 2014, Springer Science + Business Media

    Dr Henry R Kranzler

  49. GRIK1 genotype and daily expectations of alcohol’s positive effects moderate the reduction of heavy drinking by topiramate.

    Article • Experimental and Clinical Psychopharmacology, January 2014, American Psychological Association (APA)

    Dr Henry R Kranzler

  50. Multi-view biclustering for genotype-phenotype association studies of complex diseases

    Article • December 2013, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Henry R Kranzler

  51. An Interpersonal Model of Addiction Relapse

    Article • Addictive Disorders & Their Treatment, December 2013, Wolters Kluwer Health

    Dr Henry R Kranzler

  52. Clinical Manual of Addiction Psychopharmacology

    Article • November 2013, American Psychiatric Association

    Dr Henry R Kranzler

  53. Genome-wide Association Study Identifies New Susceptibility Loci for Posttraumatic Stress Disorder

    Article • Biological Psychiatry, November 2013, Elsevier

    Dr Henry R Kranzler

  54. Association of Gamma-Aminobutyric Acid A Receptor α2 Gene (GABRA2) with Alcohol Use Disorder

    Article • Neuropsychopharmacology, October 2013, Springer Science + Business Media

    Dr Henry R Kranzler

  55. Quadratic optimization to identify highly heritable quantitative traits from complex phenotypic features

    Article • August 2013, ACM (Association for Computing Machinery)

    Dr Henry R Kranzler

  56. Deep resequencing of 17 glutamate system genes identifies rare variants inDISC1andGRIN2Baffecting risk of opioid dependence

    Article • Addiction Biology, July 2013, Wiley

    Dr Henry R Kranzler

  57. Pharmacological Treatments for Heavy Drinking

    Article • Psychiatric News, July 2013, American Psychiatric Association

    Dr Henry R Kranzler

  58. Profiling of Childhood Adversity-Associated DNA Methylation Changes in Alcoholic Patients and Healthy Controls

    Article • PLoS ONE, June 2013, PLOS

    Dr Henry R Kranzler

  59. Varenicline and neuronal nicotinic acetylcholine receptors: A new approach to the treatment of co-occurring alcohol and nicotine addiction?

    Article • American Journal on Addictions, May 2013, Wiley

    Dr Henry R Kranzler

  60. Insomnia in Alcohol Dependence: Predictors of Symptoms in a Sample of Veterans Referred from Primary Care

    Article • American Journal on Addictions, March 2013, Wiley

    Dr Henry R Kranzler

  61. Major Depression and PTSD in Pregnant Smokers Enrolled in Nicotine Gum Treatment Trial

    Article • American Journal on Addictions, January 2013, Wiley

    Dr Henry R Kranzler

  62. Ordered subset linkage analysis based on admixture proportion identifies new linkage evidence for alcohol dependence in African-Americans

    Article • Human Genetics, December 2012, Springer Science + Business Media

    Dr Henry R Kranzler

  63. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity

    Article • Addiction Biology, November 2012, Wiley

    Dr Henry R Kranzler

  64. A multi-objective program for quantitative subtyping of clinically relevant phenotypes

    Article • October 2012, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Henry R Kranzler

  65. Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors

    Article • Addictive Behaviors, October 2012, Elsevier

    Dr Henry R Kranzler

  66. Linkage Analysis Followed by Association Show NRG1 Associated with Cannabis Dependence in African Americans

    Article • Biological Psychiatry, October 2012, Elsevier

    Dr Henry R Kranzler

  67. Identification of POMC Exonic Variants Associated with Substance Dependence and Body Mass Index

    Article • PLoS ONE, September 2012, PLOS

    Dr Henry R Kranzler

  68. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence

    Article • Journal of Human Genetics, August 2012, Springer Science + Business Media

    Dr Henry R Kranzler

  69. GABRA2 Genotype, Impulsivity, and Body Mass

    Article • American Journal on Addictions, August 2012, Wiley

    Dr Henry R Kranzler

  70. Personalized Treatment of Alcohol Dependence

    Article • Current Psychiatry Reports, July 2012, Springer Science + Business Media

    Dr Henry R Kranzler

  71. Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment

    Article • Addiction Biology, July 2012, Wiley

    Dr Henry R Kranzler

  72. GABRA2 markers moderate the subjective effects of alcohol

    Article • Addiction Biology, April 2012, Wiley

    Dr Henry R Kranzler

  73. The 5-HTTLPR polymorphism moderates the effect of stressful life events on drinking behavior in college students of African descent

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2012, Wiley

    Dr Henry R Kranzler

  74. Pilot Study of iPS-Derived Neural Cells to Examine Biologic Effects of Alcohol on Human Neurons In Vitro

    Article • Alcoholism Clinical and Experimental Research, April 2012, Wiley

    Dr Henry R Kranzler

  75. Association of COL25A1 with Comorbid Antisocial Personality Disorder and Substance Dependence

    Article • Biological Psychiatry, April 2012, Elsevier

    Dr Henry R Kranzler

  76. Autosomal linkage scan for loci predisposing to comorbid dependence on multiple substances

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, February 2012, Wiley

    Dr Henry R Kranzler

  77. M3: an improved SNP calling algorithm for Illumina BeadArray data

    Article • Bioinformatics, December 2011, Oxford University Press (OUP)

    Dr Henry R Kranzler

  78. A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, October 2011, Wiley

    Dr Henry R Kranzler

  79. Post‐Treatment Outcomes in a Double‐Blind, Randomized Trial of Sertraline for Alcohol Dependence

    Article • Alcoholism Clinical and Experimental Research, October 2011, Wiley

    Dr Henry R Kranzler

  80. 5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder

    Article • Psychiatric Genetics, October 2011, Wolters Kluwer Health

    Dr Henry R Kranzler

  81. Comparison of Alcoholism Subtypes as Moderators of the Response to Sertraline Treatment

    Article • Alcoholism Clinical and Experimental Research, September 2011, Wiley

    Dr Henry R Kranzler

  82. A Genomewide Linkage Scan of Cocaine Dependence and Major Depressive Episode in Two Populations

    Article • Neuropsychopharmacology, August 2011, Springer Science + Business Media

    Dr Henry R Kranzler

  83. Agitated depression in substance dependence

    Article • Drug and Alcohol Dependence, July 2011, Elsevier

    Dr Henry R Kranzler

  84. Empirically derived subtypes of opioid use and related behaviors

    Article • Addiction, April 2011, Wiley

    Dr Henry R Kranzler

  85. Association of CHRNA4 polymorphisms with smoking behavior in two populations

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, March 2011, Wiley

    Dr Henry R Kranzler

  86. Variation in Genes Encoding the Neuroactive Steroid Synthetic Enzymes 5α-Reductase Type 1 and 3α-Reductase Type 2 Is Associated With Alcohol Dependence

    Article • Alcoholism Clinical and Experimental Research, February 2011, Wiley

    Dr Henry R Kranzler

  87. Variation in NGFB is associated with primary affective disorders in women

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, February 2011, Wiley

    Dr Henry R Kranzler

  88. How Should Addiction-Related Research at the National Institutes of Health be Reorganized?

    Article • Frontiers in Psychiatry, January 2011, Frontiers

    Dr Henry R Kranzler

  89. Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics

    Article • Addiction Biology, November 2010, Wiley

    Dr Henry R Kranzler

  90. Variation in the Nicotinic Acetylcholine Receptor Gene Cluster CHRNA5–CHRNA3–CHRNB4 and Its Interaction with Recent Tobacco Use Influence Cognitive Flexibility

    Article • Neuropsychopharmacology, July 2010, Springer Science + Business Media

    Dr Henry R Kranzler

  91. Placebo-Controlled Trial of Zonisamide for the Treatment of Alcohol Dependence

    Article • Journal of Clinical Psychopharmacology, June 2010, Wolters Kluwer Health

    Dr Henry R Kranzler

  92. In Reply

    Article • Archives of General Psychiatry, June 2010, American Medical Association (AMA)

    Dr Henry R Kranzler

  93. A Prospective Cohort Study Investigating Factors Associated With Depression During Medical Internship

    Article • Archives of General Psychiatry, June 2010, American Medical Association (AMA)

    Dr Henry R Kranzler

  94. Pharmacogenetics of Alcohol and Alcohol Dependence Treatment

    Article • Current Pharmaceutical Design, June 2010, Bentham Science Publishers

    Dr Henry R Kranzler

  95. PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS

    Article • Value in Health, May 2010, Elsevier

    Dr Henry R Kranzler

  96. Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress Disorder

    Article • Neuropsychopharmacology, April 2010, Springer Science + Business Media

    Dr Henry R Kranzler

  97. Effects of Naltrexone Treatment for Alcohol-Related Disorders on Healthcare Costs in an Insured Population

    Article • Alcoholism Clinical and Experimental Research, April 2010, Wiley

    Dr Henry R Kranzler

  98. Analysis of extreme drinking in patients with alcohol dependence using Pareto regression

    Article • Statistics in Medicine, March 2010, Wiley

    Dr Henry R Kranzler

  99. Adolescent cannabis use increases risk for cocaine-induced paranoia

    Article • Drug and Alcohol Dependence, March 2010, Elsevier

    Dr Henry R Kranzler

  100. A Functional Serotonin Transporter Gene Polymorphism and Depressive Effects Associated With Interferon-α Treatment

    Article • Psychosomatics, March 2010, Elsevier

    Dr Henry R Kranzler

  101. Methamphetamine and Paranoia: The Methamphetamine Experience Questionnaire

    Article • American Journal on Addictions, February 2010, Wiley

    Dr Henry R Kranzler

  102. Confirmation and Generalization of an Alcohol-Dependence Locus on Chromosome 10q

    Article • Neuropsychopharmacology, February 2010, Springer Science + Business Media

    Dr Henry R Kranzler

  103. A genomewide ordered-subset linkage analysis for alcohol dependence in African-Americans

    Article • Genome Biology, January 2010, Springer Science + Business Media

    Dr Henry R Kranzler

  104. Adverse childhood events as risk factors for substance dependence: Partial mediation by mood and anxiety disorders

    Article • Addictive Behaviors, January 2010, Elsevier

    Dr Henry R Kranzler

  105. Functional polymorphisms in the serotonin 1B receptor gene (HTR1B) predict self‐reported anger and hostility among young men

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, December 2009, Wiley

    Dr Henry R Kranzler

  106. Subtypes of major depression in substance dependence

    Article • Addiction, September 2009, Wiley

    Dr Henry R Kranzler

  107. Measurement of admixture proportions and description of admixture structure in different U.S. populations

    Article • Human Mutation, September 2009, Hindawi Publishing Corporation

    Dr Henry R Kranzler

  108. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, September 2009, Taylor & Francis

    Dr Henry R Kranzler

  109. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, September 2009, Taylor & Francis

    Dr Henry R Kranzler

  110. Targeted Naltrexone for Problem Drinkers

    Article • Journal of Clinical Psychopharmacology, August 2009, Wolters Kluwer Health

    Dr Henry R Kranzler

  111. Cognitive Flexibility is Associated with KIBRA Variant and Modulated by Recent Tobacco Use

    Article • Neuropsychopharmacology, July 2009, Springer Science + Business Media

    Dr Henry R Kranzler

  112. Genetics of alcohol dependence

    Article • Human Genetics, June 2009, Springer Science + Business Media

    Dr Henry R Kranzler

  113. Sources of Unreliability in the Diagnosis of Substance Dependence

    Article • Journal of Studies on Alcohol and Drugs, May 2009, Alcohol Research Documentation, Inc.

    Dr Henry R Kranzler

  114. Effect of Extended‐Release Naltrexone (XR‐NTX) on Quality of Life in Alcohol‐Dependent Patients

    Article • Alcoholism Clinical and Experimental Research, January 2009, Wiley

    Dr Henry R Kranzler

  115. Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty

    Article • Drug and Alcohol Dependence, January 2009, Elsevier

    Dr Henry R Kranzler

  116. Persistence with oral naltrexone for alcohol treatment: implications for health‐care utilization

    Article • Addiction, October 2008, Wiley

    Dr Henry R Kranzler

  117. MultipleOPRgenes influence personality traits in substance dependent and healthy subjects in two American populations

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, October 2008, Wiley

    Dr Henry R Kranzler

  118. Nicotine Gum for Pregnant Smokers

    Article • Obstetrics and Gynecology, October 2008, Wolters Kluwer Health

    Dr Henry R Kranzler

  119. GENETIC STUDY: Tryptophan hydroxylase 2 gene and alcohol use among college students

    Article • Addiction Biology, August 2008, Wiley

    Dr Henry R Kranzler

  120. Effects of Prenatal Tobacco Exposure on Gene Expression Profiling in Umbilical Cord Tissue

    Article • Pediatric Research, August 2008, Springer Science + Business Media

    Dr Henry R Kranzler

  121. Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers

    Article • Alcoholism Clinical and Experimental Research, July 2008, Wiley

    Dr Henry R Kranzler

  122. Substance dependence low-density whole genome association study in two distinct American populations

    Article • Human Genetics, April 2008, Springer Science + Business Media

    Dr Henry R Kranzler

  123. Topiramate as Treatment for Alcohol Dependence—Reply

    Article • JAMA, January 2008, American Medical Association (AMA)

    Dr Henry R Kranzler

  124. Acamprosate Efficacy in Alcohol‐Dependent Patients: Summary of Results from Three Pivotal Trials

    Article • American Journal on Addictions, January 2008, Wiley

    Dr Henry R Kranzler

  125. The validity of cocaine dependence subtypes

    Article • Addictive Behaviors, January 2008, Elsevier

    Dr Henry R Kranzler

  126. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism

    Article • The World Journal of Biological Psychiatry, January 2008, Taylor & Francis

    Dr Henry R Kranzler

  127. ADH7 variation modulates extraversion and conscientiousness in substance-dependent subjects

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2008, Wiley

    Dr Henry R Kranzler

  128. Letter to the Editor

    Article • American Journal on Addictions, January 2008, Wiley

    Dr Henry R Kranzler

  129. Genetics of Substance Dependence

    Article • November 2007, World Scientific Pub Co Pte Lt

    Dr Henry R Kranzler

  130. Variation in GABRA2 Predicts Drinking Behavior in Project MATCH Subjects

    Article • Alcoholism Clinical and Experimental Research, November 2007, Wiley

    Dr Henry R Kranzler

  131. CNR1 Variation Modulates Risk for Drug and Alcohol Dependence

    Article • Biological Psychiatry, September 2007, Elsevier

    Dr Henry R Kranzler

  132. Memantine for Alcohol Dependence: An Open-label Pilot Study

    Article • Addictive Disorders & Their Treatment, June 2007, Wolters Kluwer Health

    Dr Henry R Kranzler

  133. Brief motivational enhancement and coping skills interventions for heavy drinking

    Article • Addictive Behaviors, June 2007, Elsevier

    Dr Henry R Kranzler

  134. Personality Traits of Agreeableness and Extraversion are Associated with ADH4 Variation

    Article • Biological Psychiatry, March 2007, Elsevier

    Dr Henry R Kranzler

  135. Transdermal nicotine for smoking cessation in postmenopausal women

    Article • Addictive Behaviors, February 2007, Elsevier

    Dr Henry R Kranzler

  136. Alcohol treatment utilization: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions

    Article • Drug and Alcohol Dependence, January 2007, Elsevier

    Dr Henry R Kranzler

  137. Genomewide Linkage Scan for Nicotine Dependence: Identification of a Chromosome 5 Risk Locus

    Article • Biological Psychiatry, January 2007, Elsevier

    Dr Henry R Kranzler

  138. The serotonin transporter gene and stress reactivity in daily life

    Article • January 2007, American Psychological Association (APA)

    Dr Henry R Kranzler

  139. Demographic changes and marker properties affect detection of human population differentiation

    Article • BMC Genetics, January 2007, Springer Science + Business Media

    Dr Henry R Kranzler

  140. Comorbid Psychiatric Diagnoses and Their Association with Cocaine-Induced Psychosis in Cocaine-Dependent Subjects

    Article • American Journal on Addictions, January 2007, Wiley

    Dr Henry R Kranzler

  141. Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans

    Article • Human Molecular Genetics, December 2006, Oxford University Press (OUP)

    Dr Henry R Kranzler

  142. Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia

    Article • Psychiatric Genetics, December 2006, Wolters Kluwer Health

    Dr Henry R Kranzler

  143. Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence: A meta-analysis

    Article • Drug and Alcohol Dependence, July 2006, Elsevier

    Dr Henry R Kranzler

  144. Diplotype Trend Regression Analysis of the ADH Gene Cluster and the ALDH2 Gene: Multiple Significant Associations with Alcohol Dependence

    Article • The American Journal of Human Genetics, June 2006, Elsevier

    Dr Henry R Kranzler

  145. Evidence-Based Treatments for Alcohol Dependence

    Article • JAMA, May 2006, American Medical Association (AMA)

    Dr Henry R Kranzler

  146. Genomewide Linkage Scan for Opioid Dependence and Related Traits

    Article • The American Journal of Human Genetics, May 2006, Elsevier

    Dr Henry R Kranzler

  147. Extended-Release Intramuscular Naltrexone

    Article • Drugs, January 2006, Springer Science + Business Media

    Dr Henry R Kranzler

  148. Association study of theCNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2006, Wiley

    Dr Henry R Kranzler

  149. The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers.

    Article • Experimental and Clinical Psychopharmacology, January 2006, American Psychological Association (APA)

    Dr Henry R Kranzler

  150. ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies

    Article • Pharmacogenetics and Genomics, November 2005, Wolters Kluwer Health

    Dr Henry R Kranzler

  151. ADH4 Gene Variation is Associated with Alcohol Dependence and Drug Dependence in European Americans: Results from HWD Tests and Case–Control Association Studies

    Article • Neuropsychopharmacology, October 2005, Nature

    Dr Henry R Kranzler

  152. The contribution of genetics to addiction therapy approaches

    Article • Pharmacology & Therapeutics, October 2005, Elsevier

    Dr Henry R Kranzler

  153. CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case–control structured association study

    Article • Human Molecular Genetics, July 2005, Oxford University Press (OUP)

    Dr Henry R Kranzler

  154. Genomewide linkage scan for cocaine dependence and related traits: Significant linkages for a cocaine-related trait and cocaine-induced paranoia

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, July 2005, Wiley

    Dr Henry R Kranzler

  155. Does Effect Size in Naltrexone Trials for Alcohol Dependence Differ for Single-Site vs. Multi-Center Studies?

    Article • Alcoholism Clinical and Experimental Research, June 2005, Wiley

    Dr Henry R Kranzler

  156. Response to Dr. Kopke's comments on haplotypes at the OPRM1 locus

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2005, Wiley

    Dr Henry R Kranzler

  157. Practical population group assignment with selected informative markers: Characteristics and properties of Bayesian clustering via STRUCTURE

    Article • Genetic Epidemiology, March 2005, Wiley

    Dr Henry R Kranzler

  158. Meta‐analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2005, Wiley

    Dr Henry R Kranzler

  159. Incentive program decreases no-shows in nontreatment substance abuse research.

    Article • Experimental and Clinical Psychopharmacology, January 2005, American Psychological Association (APA)

    Dr Henry R Kranzler

  160. Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis

    Article • January 2005, American Psychological Association (APA)

    Dr Henry R Kranzler

  161. Drinking to cope: a comparison of questionnaire and electronic diary reports.

    Article • Journal of Studies on Alcohol, January 2005, Alcohol Research Documentation, Inc.

    Dr Henry R Kranzler

  162. A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence

    Article • Journal of Clinical Psychopharmacology, August 2004, Wolters Kluwer Health

    Dr Henry R Kranzler

  163. Allelic and haplotypic association of GABRA2 with alcohol dependence

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, July 2004, Wiley

    Dr Henry R Kranzler

  164. Naltrexone Depot for Treatment of Alcohol Dependence: A Multicenter, Randomized, Placebo‐Controlled Clinical Trial

    Article • Alcoholism Clinical and Experimental Research, July 2004, Wiley

    Dr Henry R Kranzler

  165. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment

    Article • Drug and Alcohol Dependence, June 2004, Elsevier

    Dr Henry R Kranzler

  166. Association study of personality factors and the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1)

    Article • Psychiatric Genetics, June 2004, Wolters Kluwer Health

    Dr Henry R Kranzler

  167. Typologies of drug dependence: comparative validity of a multivariate and four univariate models

    Article • Drug and Alcohol Dependence, March 2004, Elsevier

    Dr Henry R Kranzler

  168. Nefazodone Treatment of Comorbid Alcohol Dependence and Major Depression

    Article • Alcoholism Clinical and Experimental Research, March 2004, Wiley

    Dr Henry R Kranzler

  169. CALCYON gene variation, schizophrenia, and cocaine dependence

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Dr Henry R Kranzler

  170. Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Dr Henry R Kranzler

  171. Nogo 3′-untranslated region CAA insertion: failure to replicate association with schizophrenia and demonstration of marked population difference in frequency of the insertion

    Article • Molecular Brain Research, January 2004, Elsevier

    Dr Henry R Kranzler

  172. Self-Efficacy as a Predictor of Relapse During Treatment for Alcohol Dependence

    Article • Addictive Disorders & Their Treatment, December 2003, Wolters Kluwer Health

    Dr Henry R Kranzler

  173. Psychometric Properties of the Short Index of Problems as a Measure of Recent Alcohol‐Related Problems

    Article • Alcoholism Clinical and Experimental Research, September 2003, Wiley

    Dr Henry R Kranzler

  174. Measurement and Prediction of Medication Compliance in Problem Drinkers

    Article • Alcoholism Clinical and Experimental Research, August 2003, Wiley

    Dr Henry R Kranzler

  175. Barriers to the Use of Medications to Treat Alcoholism

    Article • American Journal on Addictions, July 2003, Wiley

    Dr Henry R Kranzler

  176. Effects of Ondansetron in Early‐ Versus Late‐Onset Alcoholics: A Prospective, Open‐Label Study

    Article • Alcoholism Clinical and Experimental Research, July 2003, Wiley

    Dr Henry R Kranzler

  177. Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers

    Article • Addiction, June 2003, Wiley

    Dr Henry R Kranzler

  178. Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐Americans

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, June 2003, Wiley

    Dr Henry R Kranzler

  179. Targeted Naltrexone for Early Problem Drinkers

    Article • Journal of Clinical Psychopharmacology, June 2003, Wolters Kluwer Health

    Dr Henry R Kranzler

  180. Salty and Sour Taste Characteristics and Risk of Alcoholism

    Article • Alcoholism Clinical and Experimental Research, June 2003, Wiley

    Dr Henry R Kranzler

  181. Salty and Sour Taste Characteristics and Risk of Alcoholism

    Article • Alcoholism Clinical and Experimental Research, June 2003, Wiley

    Dr Henry R Kranzler

  182. INTRODUCTION

    Article • American Journal on Addictions, May 2003, Wiley

    Dr Henry R Kranzler

  183. Dual Diagnosis: Alcoholism and Co‐Morbid Psychiatric Disorders

    Article • American Journal on Addictions, May 2003, Wiley

    Dr Henry R Kranzler

  184. Physicians’ opinions about medications to treat alcoholism

    Article • Addiction, May 2003, Wiley

    Dr Henry R Kranzler

  185. Effect of Maternal Smoking on Fetal Catecholamine Concentrations at Birth

    Article • Pediatric Research, January 2003, Springer Science + Business Media

    Dr Henry R Kranzler

  186. Barriers to the Use of Medications to Treat Alcoholism

    Article • American Journal on Addictions, January 2003, Wiley

    Dr Henry R Kranzler

  187. Pharmacotherapies to enhance smoking cessation during pregnancy

    Article • Drug and Alcohol Review, January 2003, Wiley

    Dr Henry R Kranzler

  188. The Effect of Cigarette Smoking on Fetal Heart Rate Characteristics

    Article • Obstetrics and Gynecology, October 2002, Wolters Kluwer Health

    Dr Henry R Kranzler

  189. Screening for health behaviors in ambulatory clinical settings

    Article • Addictive Behaviors, September 2002, Elsevier

    Dr Henry R Kranzler

  190. Association Study of Alcoholism Subtypes with a Functional Promoter Polymorphism in the Serotonin Transporter Protein Gene

    Article • Alcoholism Clinical and Experimental Research, September 2002, Wiley

    Dr Henry R Kranzler

  191. Genetic variation and drug dependence risk factors

    Article • August 2002, Cambridge University Press

    Dr Henry R Kranzler

  192. The Effect of Cigarette Smoking on Fetal Heart Rate Characteristics

    Article • Obstetrics and Gynecology, May 2002, Wolters Kluwer Health

    Dr Henry R Kranzler

  193. PMH44 SURVEY AND STATED PREFERENCE TECHNIQUES FOR ESTIMATING THE DEMAND FOR ALCOHOLISM MEDICATIONS

    Article • Value in Health, May 2002, Elsevier

    Dr Henry R Kranzler

  194. Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism

    Article • Biological Psychiatry, April 2002, Elsevier

    Dr Henry R Kranzler

  195. Ms. Sandstrom and Dr. Kranzler Reply

    Article • American Journal of Psychiatry, March 2002, American Psychiatric Association

    Dr Henry R Kranzler

  196. Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of Alcohol

    Article • Alcoholism Clinical and Experimental Research, March 2002, Wiley

    Dr Henry R Kranzler

  197. The Status of Serotonin-Selective Pharmacotherapy in the Treatment of Alcohol Dependence

    Article • January 2002, Springer Science + Business Media

    Dr Henry R Kranzler

  198. Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis

    Article • Alcoholism Clinical and Experimental Research, September 2001, Wiley

    Dr Henry R Kranzler

  199. Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

    Article • Alcoholism Clinical and Experimental Research, September 2001, Wiley

    Dr Henry R Kranzler

  200. PMH32: BARRIERS TO THE USE OF MEDICATIONS TO TREAT ALCOHOLISM

    Article • Value in Health, September 2001, Elsevier

    Dr Henry R Kranzler

  201. Reliability of personality disorder symptoms and personality traits in substance-dependent inpatients.

    Article • Journal of Abnormal Psychology, May 2001, American Psychological Association (APA)

    Dr Henry R Kranzler

  202. Sweet Taste Preference as a Risk Factor for Alcohol Dependence

    Article • American Journal of Psychiatry, May 2001, American Psychiatric Association

    Dr Henry R Kranzler

  203. Adverse effects of oral naltrexone: analysis of data from two clinical trials

    Article • Psychopharmacology, April 2001, Springer Science + Business Media

    Dr Henry R Kranzler

  204. Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence

    Article • Journal of Clinical Psychopharmacology, April 2001, Wolters Kluwer Health

    Dr Henry R Kranzler

  205. Reliability of personality disorder symptoms and personality traits in substance-dependent inpatients.

    Article • Journal of Abnormal Psychology, January 2001, American Psychological Association (APA)

    Dr Henry R Kranzler

  206. Medications for Alcohol Dependence—New Vistas

    Article • JAMA, August 2000, American Medical Association (AMA)

    Dr Henry R Kranzler

  207. Variant detection at the ? opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence

    Article • Human Genetics, July 2000, Springer Science + Business Media

    Dr Henry R Kranzler

  208. Personality and substance use disorders as predictors of criminality

    Article • Comprehensive Psychiatry, July 2000, Elsevier

    Dr Henry R Kranzler

  209. Variant detection at the δ opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence

    Article • Human Genetics, July 2000, Springer Science + Business Media

    Dr Henry R Kranzler

  210. Family-Based study of DRD2 alleles in alcohol and drug dependence

    Article • American Journal of Medical Genetics, January 2000, Wiley

    Dr Henry R Kranzler

  211. Give them prizes and they will come: Contingency management for treatment of alcohol dependence.

    Article • Journal of Consulting and Clinical Psychology, January 2000, American Psychological Association (APA)

    Dr Henry R Kranzler

  212. Factor replicability and validity of the Temperament and Character Inventory in substance-dependent patients.

    Article • Psychological Assessment, December 1999, American Psychological Association (APA)

    Dr Henry R Kranzler

  213. Rates of Personality Disorders in Substance Abusers: A Comparison Between DSM-III-R and DSM-IV

    Article • Journal of Personality Disorders, December 1999, Guilford Publications

    Dr Henry R Kranzler

  214. Using cue reactivity to evaluate medications for treatment of cocaine dependence: a critical review

    Article • Addiction, November 1999, Wiley

    Dr Henry R Kranzler

  215. PHARMACOLOGIC TREATMENTS FOR DRUG AND ALCOHOL DEPENDENCE

    Article • Psychiatric Clinics of North America, June 1999, Elsevier

    Dr Henry R Kranzler

  216. No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans

    Article • Biological Psychiatry, February 1999, Elsevier

    Dr Henry R Kranzler

  217. Validity of the Obsessive Compulsive Drinking Scale (OCDS)

    Article • Alcoholism Clinical and Experimental Research, January 1999, Wiley

    Dr Henry R Kranzler

  218. Factor replicability and validity of the Temperament and Character Inventory in substance-dependent patients.

    Article • Psychological Assessment, January 1999, American Psychological Association (APA)

    Dr Henry R Kranzler

  219. The validity of self-reported cocaine use in two groups of cocaine abusers.

    Article • Journal of Consulting and Clinical Psychology, January 1999, American Psychological Association (APA)

    Dr Henry R Kranzler

  220. Validity of the Obsessive Compulsive Drinking Scale (OCDS): Does Craving Predict Drinking Behavior?

    Article • Alcoholism Clinical and Experimental Research, January 1999, Wiley

    Dr Henry R Kranzler

  221. Dr. Kranzler and Colleagues Reply

    Article • American Journal of Psychiatry, November 1998, American Psychiatric Association

    Dr Henry R Kranzler

  222. PROP taster status and parental history of alcohol dependence

    Article • Drug and Alcohol Dependence, October 1998, Elsevier

    Dr Henry R Kranzler

  223. Neuropsychologic findings in cocaine-dependent outpatients

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, October 1998, Elsevier

    Dr Henry R Kranzler

  224. Variants in the ?2A AR adrenergic receptor gene in psychiatric patients

    Article • American Journal of Medical Genetics, September 1998, Wiley

    Dr Henry R Kranzler

  225. Population Studies of Polymorphisms at Loci of Neuropsychiatric Interest (Tryptophan Hydroxylase (TPH), Dopamine Transporter Protein (SLC6A3), D3 Dopamine Receptor (DRD3), Apolipoprotein E (APOE), μ Opioid Receptor (OPRM1), and Ciliary Neurotrophic Fac...

    Article • Genomics, September 1998, Elsevier

    Dr Henry R Kranzler

  226. Association of Alcohol or Other Drug Dependence with Alleles of the mu Opioid Receptor Gene (OPRM1)

    Article • Alcoholism Clinical and Experimental Research, September 1998, Wiley

    Dr Henry R Kranzler

  227. Sustained-Release Naltrexone for Alcoholism Treatment

    Article • Alcoholism Clinical and Experimental Research, August 1998, Wiley

    Dr Henry R Kranzler

  228. Sustained‐Release Naltrexone for Alcoholism Treatment: A Preliminary Study

    Article • Alcoholism Clinical and Experimental Research, August 1998, Wiley

    Dr Henry R Kranzler

  229. Stage of Change as a Predictor of Abstinence among Alcohol‐Dependent Subjects in Pharmacotherapy Trials

    Article • Substance Abuse, June 1998, SAGE Publications

    Dr Henry R Kranzler

  230. Treatment of Inhalant-Induced Psychotic Disorder With Carbamazepine Versus Haloperidol

    Article • Psychiatric Services, June 1998, American Psychiatric Association

    Dr Henry R Kranzler

  231. Personality Disorders in Substance Abusers: Relation to Substance Use

    Article • The Journal of Nervous and Mental Disease, February 1998, Wolters Kluwer Health

    Dr Henry R Kranzler

  232. Effects of naltrexone on cue-elicited craving for alcohol and cocaine

    Article • Drug and Alcohol Dependence, December 1997, Elsevier

    Dr Henry R Kranzler

  233. Is the medication bottle half full or half empty?

    Article • Addiction, August 1997, Wiley

    Dr Henry R Kranzler

  234. No allelic association of an exon 13 polymorphism of the Gsα gene to alcohol and/or drug dependence

    Article • Addiction Biology, July 1997, Wiley

    Dr Henry R Kranzler

  235. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal

    Article • Psychopharmacology, May 1997, Springer Science + Business Media

    Dr Henry R Kranzler

  236. Targeted naltrexone treatment of early problem drinkers

    Article • Addictive Behaviors, May 1997, Elsevier

    Dr Henry R Kranzler

  237. Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients

    Article • Drug and Alcohol Dependence, May 1997, Elsevier

    Dr Henry R Kranzler

  238. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

    Article • January 1997, American Psychological Association (APA)

    Dr Henry R Kranzler

  239. Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers.

    Article • Journal of Abnormal Psychology, January 1997, American Psychological Association (APA)

    Dr Henry R Kranzler

  240. Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive‐Behavioral Therapy in Type B Alcoholics

    Article • Alcoholism Clinical and Experimental Research, December 1996, Wiley

    Dr Henry R Kranzler

  241. Ritanserin in the treatment of alcohol dependence - a multi-center clinical trial

    Article • Psychopharmacology, November 1996, Springer Science + Business Media

    Dr Henry R Kranzler

  242. Validity of the SCID in substance abuse patients

    Article • Addiction, June 1996, Wiley

    Dr Henry R Kranzler

  243. Validity of the SCID in substance abuse patients

    Article • Addiction, June 1996, Wiley

    Dr Henry R Kranzler

  244. No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence

    Article • Addiction Biology, June 1996, Wiley

    Dr Henry R Kranzler

  245. Elevated Rates of Early Discontinuation from Pharmacotherapy Trials in Alcoholics and Drug Abusers

    Article • Alcoholism Clinical and Experimental Research, February 1996, Wiley

    Dr Henry R Kranzler

  246. Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable

    Article • Drug and Alcohol Dependence, November 1995, Elsevier

    Dr Henry R Kranzler

  247. Carbamazepine and cocaine-cue reactivity

    Article • Drug and Alcohol Dependence, October 1995, Elsevier

    Dr Henry R Kranzler

  248. Handbook of experimental pharmacology, vol. 114: The pharmacology of alcohol abuse. Edited by Henry R. Kranzler. Springer-Verlag, Berlin, 1995. pp. 548. DM 498. ISBN 3-540-57125-6

    Article • Human Psychopharmacology Clinical and Experimental, July 1995, Wiley

    Dr Henry R Kranzler

  249. Validity of the Distinction Between “Substance‐Induced” and “Independent” Depression and Anxiety Disorders

    Article • American Journal on Addictions, April 1995, Wiley

    Dr Henry R Kranzler

  250. Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia

    Article • Neuropsychopharmacology, April 1995, Nature

    Dr Henry R Kranzler

  251. The Pharmacology of Alcohol Abuse

    Article • January 1995, Springer Science + Business Media

    Dr Henry R Kranzler

  252. Validity of the Distinction Between “Substance-Induced” and “Independent” Depressio and Anxiety Disorders

    Article • American Journal on Addictions, January 1995, Wiley

    Dr Henry R Kranzler

  253. Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia

    Article • Neuropsychopharmacology, November 1994, Springer Science + Business Media

    Dr Henry R Kranzler

  254. Determination of fluvoxamine concentration in plasma by reversed‐phase liquid chromatography

    Article • Biomedical Chromatography, November 1994, Wiley

    Dr Henry R Kranzler

  255. Personality disorders and associated features in cocaine-dependent inpatients

    Article • Comprehensive Psychiatry, September 1994, Elsevier

    Dr Henry R Kranzler

  256. Buspirone Treatment of Anxious Alcoholics

    Article • Archives of General Psychiatry, September 1994, American Medical Association (AMA)

    Dr Henry R Kranzler

  257. Electroencephalographic activity and mood in cocaine-dependent outpatients: Effects of cocaine cue exposure

    Article • Biological Psychiatry, August 1994, Elsevier

    Dr Henry R Kranzler

  258. Patient Predictors of Irregular Discharge From Inpatient Substance Abuse Treatment

    Article • American Journal on Addictions, April 1994, Wiley

    Dr Henry R Kranzler

  259. Naltrexone and Brief Counseling to Reduce Heavy Drinking

    Article • American Journal on Addictions, April 1994, Wiley

    Dr Henry R Kranzler

  260. Patient Predictors of Irregular Discharge from Inpatient Substance Abuse Treatment

    Article • American Journal on Addictions, January 1994, Wiley

    Dr Henry R Kranzler

  261. Naltrexone and Brief Counseling to Reduce Heavy Drinking:Results of a Small Clinical Trial

    Article • American Journal on Addictions, January 1994, Wiley

    Dr Henry R Kranzler

  262. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

    Article • Journal of Consulting and Clinical Psychology, January 1994, American Psychological Association (APA)

    Dr Henry R Kranzler

  263. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

    Article • Journal of Consulting and Clinical Psychology, January 1994, American Psychological Association (APA)

    Dr Henry R Kranzler

  264. Letter to the editor

    Article • Addictive Behaviors, November 1993, Elsevier

    Dr Henry R Kranzler

  265. Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism☆

    Article • Journal of Substance Abuse Treatment, May 1993, Elsevier

    Dr Henry R Kranzler

  266. Cross system agreement for substance use disorders: DSM‐III‐R, DSM‐IV and ICD‐10

    Article • Addiction, March 1993, Wiley

    Dr Henry R Kranzler

  267. Bromocriptine and cocaine cue reactivity in cocaine‐dependent patients

    Article • British Journal of Addiction, November 1992, Wiley

    Dr Henry R Kranzler

  268. Persistent Urinary Benzoylecgonine Following Cocaine Use

    Article • American Journal on Addictions, July 1992, Wiley

    Dr Henry R Kranzler

  269. Self‐reports by alcohol and drug abuse inpatients: factors affecting reliability and validity

    Article • British Journal of Addiction, July 1992, Wiley

    Dr Henry R Kranzler

  270. Alcohol and drug abuse treatment at the University of Connecticut Health Center

    Article • British Journal of Addiction, April 1992, Wiley

    Dr Henry R Kranzler

  271. Persistent Urinary Benzoylecgonine Following Cocaine Use

    Article • American Journal on Addictions, January 1992, Wiley

    Dr Henry R Kranzler

  272. Intragastric Infusion of Ethanol by Alcoholics After Surgery for Head and Neck Cancer

    Article • American Journal on Addictions, January 1992, Wiley

    Dr Henry R Kranzler

  273. Intragastric Infusion of Ethanol by Alcoholics After Surgery for Head and Neck Cancer

    Article • American Journal on Addictions, January 1992, Wiley

    Dr Henry R Kranzler

  274. Serum Prolactin Level, Craving, and Early Discharge from Treatment in Cocaine-Dependent Patients

    Article • The American Journal of Drug and Alcohol Abuse, January 1992, Taylor & Francis

    Dr Henry R Kranzler

  275. Headaches and Psychoactive Substance Use

    Article • Headache The Journal of Head and Face Pain, October 1991, Wiley

    Dr Henry R Kranzler

  276. Substance Use Disorders in Patients With Chronic Fatigue

    Article • Psychiatric Services, September 1991, American Psychiatric Association

    Dr Henry R Kranzler

  277. The Identification and Treatment of Alcohol Abuse and Dependency

    Article • Annals of Clinical Psychiatry, December 1990, Portico

    Dr Henry R Kranzler

  278. Dental pathology and alcohol-related indicators in an outpatient clinic sample

    Article • Community Dentistry And Oral Epidemiology, August 1990, Wiley

    Dr Henry R Kranzler

  279. Giving ethanol to alcoholics in a research setting: its effect on compliance with disulfiram treatment

    Article • British Journal of Addiction, January 1990, Wiley

    Dr Henry R Kranzler

  280. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography

    Article • Journal of Chromatography A, January 1990, Elsevier

    Dr Henry R Kranzler

  281. Buspirone Treatment of Anxiety in a Patient Dependent on Alprazolam

    Article • Journal of Clinical Psychopharmacology, April 1989, Wolters Kluwer Health

    Dr Henry R Kranzler

  282. Early detection of harmful alcohol consumption: Comparison of clinical, laboratory, and self-report screening procedures

    Article • Addictive Behaviors, January 1989, Elsevier

    Dr Henry R Kranzler

  283. Use of Buspirone in an Adolescent with Overanxious Disorder

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 1988, Elsevier

    Dr Henry R Kranzler

  284. Anxiety and Depression in Substance Abuse: Clinical Implications

    Article • Medical Clinics of North America, September 1988, Elsevier

    Dr Henry R Kranzler

  285. Atypical Koro

    Article • The British Journal of Psychiatry, April 1988, Royal College of Psychiatrists

    Dr Henry R Kranzler

  286. Phenothiazine-Associated Lupus Anticoagulant and Thrombotic Disease

    Article • Psychosomatics, January 1988, Elsevier

    Dr Henry R Kranzler

  287. Psychosocial Issues Concerning a Pregnant Adolescent with Hodgkin's Disease

    Article • Journal of Psychosocial Oncology, May 1987, Taylor & Francis

    Dr Henry R Kranzler

  288. Social Drinking as a Health and Psychosocial Risk Factor

    Article • January 1987, Springer Science + Business Media

    Dr Henry R Kranzler

  289. Current Perspectives in Cultural Psychiatry. E. F. Foulks, R. M. Wintrob, J. Westermeyer and A. R. Favazza, eds

    Article • Medical Anthropology Newsletter, May 1981, Wiley

    Dr Henry R Kranzler

  290. How to measure relapse in humans

    Article • Springer Science + Business Media

    Dr Henry R Kranzler